Jane Street’s Burning Rock Biotech BNR Stock Holding History

Jane Street’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,041	Closed	-$22.4K	–	8656
2023 Q2	$22.4K	Buy	1,041 +1	+0.1%	+$27	﹤0.01%	8347
2023 Q1	$29.2K	Sell	1,040 -4,749	-82%	-$142K	﹤0.01%	8580
2022 Q4	$130K	Buy	5,789 +1,161	+25%	+$26.5K	﹤0.01%	7958
2022 Q3	$111K	Buy	4,628 +2,505	+118%	+$80.8K	﹤0.01%	8590
2022 Q2	$62K	Buy	2,123 +1,084	+104%	+$48.4K	﹤0.01%	8855
2022 Q1	$97K	Buy	+1,039	New	+$90.3K	﹤0.01%	9468
2021 Q3	–	Sell	-2,087	Closed	-$615K	–	9934
2021 Q2	$615K	Buy	+2,087	New	+$617K	﹤0.01%	6853
2020 Q3	–	Sell	-1,373	Closed	-$371K	–	7158
2020 Q2	$371K	Buy	+1,373	New	+$376K	﹤0.01%	5513

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jane Street's BNR Position: Q3 2023 in Review

Jane Street sold out of Burning Rock Biotech (BNR) in Q3 2023, closing a stake of 1,041 shares — an estimated $22.4K sold.

Jane Street first reported a position in BNR in Q2 2020 and held it in 8 quarters. The position peaked at $615K in Q2 2021. 28 funds tracked by Wall St. Rank hold BNR as of Q3 2023.

Jane Street reported no remaining Burning Rock Biotech position as of Q3 2023 after selling out during the quarter.
Jane Street sold 1,041 Burning Rock Biotech shares in Q3 2023, an estimated $22.4K.
Jane Street first reported a position in Burning Rock Biotech in Q2 2020 and held it in 8 quarters.
Jane Street's Burning Rock Biotech position peaked at $615K in Q2 2021.
28 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.